Clinical outcomes following biochemical recurrence among patients with Gleason score 9-10 prostate adenocarcinoma.

Authors

null

Kiri A Sandler

University of California Los Angeles, Los Angeles, CA

Kiri A Sandler , Fang-I Chu , Jay P. Ciezki , Richard Stock , Gregory Stephen Merrick , David Jeffrey Demanes , Daniel Eidelberg Spratt , Eyad I. Abu-Isa , Mark Pomerantz , Ashley Ross , Phuoc T. Tran , Paul L. Nguyen , Trude Baastad Wedde , Wolfgang Lilleby , Daniel Krauss , Ridwan Alam , Michael L. Steinberg , Eric M. Horwitz , Christopher R. King , Amar Upadhyaya Kishan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 102)

DOI

10.1200/JCO.2018.36.6_suppl.102

Abstract #

102

Poster Bd #

E22

Abstract Disclosures

Similar Posters

First Author: Jay P. Ciezki

First Author: Samuel L. Washington III

First Author: Pedro Isaacsson Velho